Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-063318
Filing Date
2013-12-18
Accepted
2013-12-18 12:49:36
Documents
2
Period of Report
2013-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd397842.html 4  
1 PRIMARY DOCUMENT rrd397842.xml 4 3188
2 POWER OF ATTORNEY OF ANDREW GENGOS rrd357981_405569.htm EX-24.1 4017
  Complete submission text file 0001181431-13-063318.txt   8902
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21900 BURBANK BOULEVARD 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Gengos Andrew (Reporting) CIK: 0001563623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 131284586